Dexamethasone decreases the ratio of angiopoietin-2 to angiopoietin-1, thereby promoting endothelial stabilization and reducing endothelial cell apoptosis, which is critical in reducing mortality in critically ill COVID-19 patients [36]. This evidence concerns the gene ANGPT2 and COVID-19.